Product

Portfolio
We meet the demand for critical nuclear medicine products by combining our innovative resources with strategic relationships.

We are progressing towards the commercialization of our Technetium-99m generator and have programs and collaborations in place to enable the development and rollout of new radiopharmaceutical products.
Active Pharmaceutical Ingredients IN DEVELOPMENT INDIUM-111
OXYQUINOLINE
IODINE-123
ORAL SOLUTION
*THERASPHERE ACTINIUM-225 IODINE-123 INDIUM-111
GERMANIUM-68 STRONTIUM-82 LEAD-203 LUTETIUM-177 TECHNETIUM-99M *Under contract by Boston Scientific Finished Products

This Website Uses Cookies.

We use cookies to give you the best user experience. No personal information is collected in this process.